v3.25.4
Summary of Significant Accounting Policies - Narrative (Details)
12 Months Ended
Jun. 09, 2025
USD ($)
$ / shares
shares
May 27, 2025
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Concentration Risk [Line Items]          
Assets     $ 305,406,000 $ 150,892,000  
Liabilities     75,726,000 86,261,000  
Conversion ratio   0.333      
Stock price per share (in dollars per share) | $ / shares $ 19.00        
Proceeds from initial public offering, net of underwriting discounts and commissions $ 172,600,000   $ 160,532,000 0 $ 0
Proceeds from exercise of stock options 151,600,000        
Number of reportable segments | segment     1    
Number of operating segments | segment     1    
Property, plant and equipment, useful life     3 years    
Capitalized computer     $ 4,700,000 3,400,000  
Capitalized internal-use software     3,000,000.0 2,200,000 1,700,000
Goodwill impairment     0 0 0
Long-lived asset impairment     0 0 0
Contract assets     $ 638,000 502,000  
Capitalized commissions amortization period     5 years    
Deferred commissions     $ 12,300,000 12,200,000  
Amortization of deferred commissions     3,339,000 2,643,000 1,799,000
Deferred revenue recognized     19,500,000 14,900,000  
Deferred costs $ 9,000,000.0   0 4,800,000  
Advertising cost     $ 600,000 $ 500,000 $ 800,000
Number of equity incentive plans | segment     2    
Expected dividend yield     0.00% 0.00% 0.00%
Prepaid Expenses and Other Current Assets          
Concentration Risk [Line Items]          
Contract assets     $ 600,000 $ 500,000  
Minimum          
Concentration Risk [Line Items]          
Non-cancelable term     30 days    
Maximum          
Concentration Risk [Line Items]          
Non-cancelable term     180 days    
Expected dividend yield          
Concentration Risk [Line Items]          
Warrants, measurement input     0    
Capitalized internal-use software          
Concentration Risk [Line Items]          
Property, plant and equipment, useful life     3 years    
IPO          
Concentration Risk [Line Items]          
Shares issued and sold (in shares) | shares 9,085,000        
Over-Allotment Option          
Concentration Risk [Line Items]          
Shares issued and sold (in shares) | shares 1,185,000        
Variable Interest Entity, Primary Beneficiary          
Concentration Risk [Line Items]          
Assets     $ 800,000 900,000  
Liabilities     $ 200,000 $ 200,000